Gradient Process Partners take early-stage process technologies and put them through rigorous trialling and scale-up campaigns — generating the data, the process understanding, and the technical readiness that turn promise into commercial value.
Early-stage technologies are usually rich in data at lab scale and poor in evidence at every scale that matters commercially. We close that gap.
Independent, structured assessment of a process technology: mass and energy balances, critical process parameters, failure modes, and an honest view of what's proven versus assumed.
Designed and executed trialling programmes — at bench, pilot, or demonstration scale — that generate the datasets needed for techno-economic models, regulatory files, and investment cases.
Process design, equipment specification, commissioning, and production support to carry a technology from validated concept to operating reality — without losing performance on the way up.
Every scale increase changes the physics — mixing, heat transfer, mass transfer, residence time. We design trials that expose those changes early, while they're still cheap to fix.
We agree what "validated" means for your technology — the performance targets, the scale, and the evidence a buyer, partner, or investor will need to see.
Trial protocols built around the real risks: scale-dependent physics, feedstock variability, product quality, and cost drivers — not just whether the chemistry works once.
Hands-on trialling and scale-up campaigns, run in partner facilities or on-site, with the discipline of engineers who have commissioned and operated production plants.
Results become assets: process design packages, techno-economic assessments, and data rooms that raise the commercial value of the technology itself.
Gradient Process Partners was founded by chemical and bioprocess engineers with experience spanning research, R&D, process development, design, commissioning, and production — across food, nutraceutical, pharmaceutical, biopharmaceutical, renewable energy, and sustainable materials sectors.
That breadth matters. The reasons technologies fail at scale are rarely visible from inside a single discipline or a single stage of development. We've seen where projects break — and we design trials that find those breaks before they become expensive.
Research → R&D → process development → design → commissioning → production. The full lifecycle, not just one slice of it.
Cross-sector pattern recognition: what pharma knows about validation, what food knows about cost, what energy knows about scale.
We protect the performance of a technology on the way up. What works in the flask should still work in the vessel — and we engineer for that from the first trial.
Tell us where it stands today and where it needs to get to. We'll give you a straight answer on whether — and how — we can help.
Get in touch